Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
79
CAN Quote, Financials, Valuation and Earnings
Last price:
$0.95
Seasonality move
:
-10.41%
Day range:
$0.89 - $1.00
52-week range:
$0.53 - $3.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.89x
P/B ratio:
1.84x
Volume:
123.9M
Avg. volume:
40.6M
1-year change:
-19.17%
Market cap:
$450.3M
Revenue:
$269.3M
EPS (TTM):
-$1.02
Analysts' Opinion
-
Consensus RatingCanaan has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2.67, Canaan has an estimated upside of 172.86% from its current price of $0.98.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.50 representing 100% downside risk from its current price of $0.98.
Fair Value
-
According to the consensus of 5 analysts, Canaan has 172.86% upside to fair value with a price target of $2.67 per share.
CAN vs. S&P 500
-
Over the past 5 trading days, Canaan has overperformed the S&P 500 by 39.64% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Canaan does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Canaan has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Canaan reported revenues of $82.8M.
Earnings Growth
-
Canaan earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Canaan reported earnings per share of -$0.27.
Enterprise value:
582M
EV / Invested capital:
--
Price / LTM sales:
0.89x
EV / EBIT:
--
EV / Revenue:
1.84x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.37x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$46.3M
Return On Assets:
-57.29%
Net Income Margin (TTM):
-93.62%
Return On Equity:
-91.79%
Return On Invested Capital:
-71.83%
Operating Margin:
-46.08%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $538.7M | $191.3M | $317M | $35.1M | $82.8M | |
| Gross Profit | $76M | -$230.6M | -$46.3M | -$37.3M | $646K | |
| Operating Income | -$112.1M | -$369.7M | -$190.8M | -$70.4M | -$38.1M | |
| EBITDA | -$74.6M | -$417.4M | -$218.5M | -$38.6M | -$85.4M | |
| Diluted EPS | -$0.47 | -$2.05 | -$1.02 | -$0.16 | -$0.27 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $353.1M | $908.2M | $520.8M | $321M | $435.2M | |
| Total Assets | $358.8M | $983.1M | $633.7M | $534.1M | $565.6M | |
| Current Liabilities | $269.7M | $345.2M | $83M | $110.5M | $289.9M | |
| Total Liabilities | $271M | $358.6M | $85.6M | $122.4M | $320.9M | |
| Total Equity | $87.8M | $624.5M | $548.1M | $411.7M | $244.6M | |
| Total Debt | $4.9M | -- | -- | $7.1M | $228.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -$85M | -$169.5M | |
| Cash From Investing | -- | -- | -- | $26.1M | $43.6M | |
| Cash From Financing | -- | -- | -- | $4.2M | $109.8M | |
| Free Cash Flow | -$71M | -$179.9M | -$424.4M | -$87.1M | -$173.9M | |
CAN
Sector
Market Cap
$450.3M
$83.5M
Price % of 52-Week High
29.91%
64.2%
Dividend Yield
0%
0%
Shareholder Yield
-4.35%
0.68%
1-Year Price Total Return
-19.17%
-12.88%
Beta (5-Year)
3.289
0.814
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.80
200-day SMA
Sell
Level
$1.29
Bollinger Bands (100)
Buy
Level
0.59 - 1.09
Chaikin Money Flow
Sell
Level
-702.2M
20-day SMA
Buy
Level
$0.70
Relative Strength Index (RSI14)
Buy
Level
68.98
ADX Line
Buy
Level
24.82
Williams %R
Sell
Level
-4.7952
50-day SMA
Buy
Level
$0.69
MACD (12, 26)
Buy
Level
0.06
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
551M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6339)
Sell
CA Score
(Annual)
Level (-1.2092)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.0033)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
Stock Forecast FAQ
In the current month, CAN has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CAN average analyst price target in the past 3 months is $2.67.
-
Where Will Canaan Stock Be In 1 Year?
According to analysts, the consensus estimate is that Canaan share price will rise to $2.67 per share over the next 12 months.
-
What Do Analysts Say About Canaan?
Analysts are divided on their view about Canaan share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Canaan is a Sell and believe this share price will drop from its current level to $1.50.
-
What Is Canaan's Price Target?
The price target for Canaan over the next 1-year time period is forecast to be $2.67 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CAN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Canaan is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CAN?
You can purchase shares of Canaan via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Canaan shares.
-
What Is The Canaan Share Price Today?
Canaan was last trading at $0.95 per share. This represents the most recent stock quote for Canaan. Yesterday, Canaan closed at $0.98 per share.
-
How To Buy Canaan Stock Online?
In order to purchase Canaan stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
